Company news
10x Genomics, Inc. (NASDAQ:TXG) news
10x Genomics, Inc. news releases on 6ix. Latest, Feb 18, 2025: 10x Genomics to Participate in the 45th Annual TD Cowen Health Care Conference
Press releases — page 2
10x Genomics to Participate in the 45th Annual TD Cowen Health Care Conference
February 17, 2025
10x Genomics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Outlook for 2025
February 11, 2025
10x Genomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 12, 2025
January 27, 2025
10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2024 Results
January 11, 2025
10x Genomics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 1, 2025
U.S. District Court Awards 10x Genomics Permanent Injunction in Patent Infringement Lawsuit Against Bruker Corporation's GeoMx Products
December 22, 2024
10x Genomics to Present at the Wolfe Research 2024 Healthcare Conference
November 6, 2024
TechBio Startup Cure51 Selects 10x Genomics Visium HD for New Drug Discovery Initiative
October 30, 2024
10x Genomics Reports Third Quarter 2024 Financial Results
October 28, 2024
10x Genomics Delivers 'Single Cell for a Single Cent' with New Chromium Launches
October 14, 2024
10x Genomics Announces Preliminary Select Third Quarter 2024 Results
October 8, 2024
10x Genomics Announces Mega-Scale Single Cell Analysis for One Cent Per Cell at Human Cell Atlas General Meeting
September 30, 2024
Lausanne Researchers Combine 10x Genomics' Chromium and Xenium for Novel Insights into Resistance and Potential Therapeutics for Brain Cancer
September 9, 2024
10x Genomics Unveils Chromium Xo: A Low-Cost Instrument to Expand Access to High-Performance Single Cell Research
September 2, 2024
10x Genomics to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
August 21, 2024
10x Genomics Reports Second Quarter 2024 Financial Results
August 7, 2024
10x Genomics Announces Senior Leadership Changes
August 7, 2024
10x Genomics Technology Supports TenK10K Project Led by Garvan Institute of Medical Research to Help Transform the Treatment of Complex Diseases
August 4, 2024
10x Genomics to Report Second Quarter 2024 Financial Results on August 8, 2024
July 11, 2024
10x Genomics Begins Commercial Shipments of Xenium Prime 5K Pan-Tissue and Pathways Panel
June 19, 2024
10x Genomics Launches 5,000-Plex Gene Panel for Xenium
May 28, 2024
10x Genomics to Present at the BofA Securities 2024 Healthcare Conference
May 1, 2024
10x Genomics Reports First Quarter 2024 Financial Results
April 29, 2024
10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024
April 9, 2024
10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay
March 25, 2024
10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel
March 20, 2024
10x Genomics Begins Commercial Shipments of Chromium GEM-X Products
March 12, 2024
10x Genomics to Present at the 44th Annual TD Cowen Health Care Conference
February 19, 2024
10x Genomics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Outlook for 2024
February 14, 2024
10x Genomics Expands Leadership in Single Cell Analysis with Launch of GEM-X Technology
February 6, 2024
10x Genomics to Showcase New Cutting-Edge Technologies and Highlight Innovation Roadmap at 2024 AGBT General Meeting
February 4, 2024
10x Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024
January 23, 2024
10x Genomics Announces Preliminary Fourth Quarter and Full Year 2023 Results
January 7, 2024
10x Genomics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
December 20, 2023
10x Genomics Launches Xenium Catalyst Network
December 19, 2023
Integrative Study Conducted by 10x Genomics Combines Single Cell, Spatial and In Situ Analyses to Investigate Tumor Invasiveness
December 18, 2023
High Sensitivity and Specificity of the Xenium Platform from 10x Genomics Outperforms NanoString's CosMx and Vizgen's Merscope in Benchmarking Preprint
December 12, 2023
10x Genomics and NIH CARD to Create Comprehensive Single Cell Atlas of the Human Brain
December 6, 2023
10x Genomics Wins Another Patent Infringement Case Against NanoString Technologies
November 16, 2023
10x Genomics Reports Third Quarter 2023 Financial Results
November 1, 2023
10x Genomics to Present at the Stephens 25th Annual Conference
October 31, 2023
Study Fueled by Xenium Analysis Sheds Light on Resistance Mechanisms in Model of Lethal Pediatric Brain Tumors
October 25, 2023
10x Genomics to Report Third Quarter 2023 Financial Results on November 2, 2023
October 10, 2023
10x Genomics Comments on Second UPC Preliminary Injunction Decision
October 9, 2023
10x Wins Injunction From Unified Patent Court Banning Sales of NanoString's CosMx Products in Europe
September 18, 2023
10x Genomics Expands Gene Expression Flex Offering with New High-Throughput Multiomic Profiling Kit
September 13, 2023
Study Enabled by 10x Genomics Single Cell and Spatial Technologies Explains Why Immunotherapy is More Effective for Certain Brain Tumors Than Others
September 4, 2023
10x Genomics to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
August 29, 2023
10x Genomics Surpasses 100 Xenium Analyzer Shipments
August 28, 2023
10x Genomics Reports Second Quarter 2023 Financial Results
August 2, 2023